By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...

The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...

Ocugen Inc. (NASDAQ:OCGN) is one of the 10 best penny stocks that could triple your money. On March 24, Ocugen Inc. (NASDAQ:OCGN) announced 12-month data from the Phase 2 ArMaDa clinical trial ...

An analysis of 65,061 globally recruiting clinical trials across 186 countries finds that 4,361 studies, equivalent to 6.7% ...

Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences ...

UC Berkeley School of Public Health researchers are collaborating with the FDA and industry to make drug clinical trials ...

Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...

BioNTech will present significant clinical trial data at the prestigious ASCO Annual Meeting, highlighting the advancement of its diversified oncology portfolio. The preliminary results for BNT327 and ...

Just over a month after announcing its new Clinical Data Studio, Medidata has its first big customer. Eisai announced July 25 that it is incorporating Medidata’s data studio into its clinical trial ...

Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.